John Lunger's Net Worth
$224 Thousand
Who is John Lunger?
John Lunger does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adaptimmune Therapeutics PLC, and GENOCEA BIOSCIENCES, INC..
SEC CIK
John Lunger's CIK is 0001784487
Past Insider Trading and Trends
2022 was John Lunger's most active year for acquiring shares with 3 total transactions. John Lunger's most active month to acquire stocks was the month of December. 2022 was John Lunger's most active year for disposing of shares, totalling 6 transactions. John Lunger's most active month to dispose stocks was the month of December. 2024 saw John Lunger paying a total of $0.00 for 3,109,848 shares, this is the most they've acquired in one year. In 2020 John Lunger cashed out on 7,115 shares for a total of $51,864.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.09
Chief Patient Supply OfficerJohn Lunger owns 19,015 units of American Depositary Shares representing Ordinary Shares which is worth $20,726.35. From 2019 to 2024 John Lunger disposed a total of 83,158 shares of Adaptimmune Therapeutics PLC equalling to $203,353.18.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -40.26% | -22.80K |
$0.71 | -$15,888.72 | 33.82K |
Jan 16 - Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
| -39.77% | -9.23K |
$0.85 | -$7,812.73 | 13.98K |
Jan 11 - Jan 12
| |||
Form 4
| -39.62% | -3.10K |
$0.91 | -$2,803.74 | 4.72K |
Aug 1
| |||
Form 4
| -37.94% | -4.44K |
$1.86 | -$8,249.52 | 7.26K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| -37.99% | -8.82K |
$1.73 | -$15,196.89 | 14.39K |
Jan 11 - Jan 12
| |||
Form 4
| -38.94% | -1.10K |
$1.69 | -$1,863.40 | 1.73K |
Jan 4
| |||
Form 4
| -38.18% | -2.98K |
$1.77 | -$5,290.35 | 4.83K |
Aug 1
| |||
Form 4
| -38.86% | -1.97K |
$1.68 | -$3,310.89 | 3.1K |
Jul 5
| |||
Form 4
| -37.32% | -4.37K |
$3.19 | -$13,941.78 | 7.34K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
| -37.46% | -4.85K |
$3.55 | -$17,222.21 | 8.09K |
Jan 11 - Jan 12
| |||
Form 4
| -37.88% | -1.07K |
$4.06 | -$4,348.69 | 1.75K |
Jan 4
| |||
Form 4
| -37.62% | -2.94K |
$3.58 | -$10,535.73 | 4.87K |
Aug 2
| |||
Form 4
| -37.56% | -1.91K |
$4.26 | -$8,133.16 | 3.17K |
Jul 2
| |||
Form 4
| -37.24% | -4.36K |
$5.67 | -$24,707.68 | 7.35K |
Jan 19
| |||
Form 4
| -37.45% | -1.06K |
$6.15 | -$6,509.03 | 1.77K |
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| -37.70% | -1.06K |
$5.33 | -$5,674.21 | 1.76K |
Jan 4
| |||
Form 4
| -37.42% | -4.82K |
$9.25 | -$44,612.75 | 8.07K |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
| -40.50% | -1.14K |
$5.13 | -$5,874.10 | 1.68K |
Jan 14
| |||
Form 4
| -40.64% | -1.15K |
$1.20 | -$1,377.60 | 1.68K |
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GENOCEA BIOSCIENCES, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||